Company Profile of LIAOYUAN CITY BAIKANG PHARMACEUTICAL CO.,LTD.

Liaoyuan City Baikang Pharmaceutical Co., Ltd., an enterprise with a history of about 66 years, is the API export base and the production base of Sansheng Shares. Baikang Pharmaceutical has 102 varieties of products in total, including 20 APIs and 82 formulations in tablets, capsules, and granules form. The leading varieties of APIs are paracetamol, cloperastine hydrochloride, levofloxacin methylate, benorilate, moroxydine hydrochloride, procaine hydrochloride, diphenhydramine hydrochloride, furazolidone and benproperine phosphate. The annual formulation output of Baikang Pharmaceutical is more than 2 billion, mainly including compound paracetamol and diphenhydramine hydrochloride tablets, cloperastine hydrochloride tablets, paracetamol tablets, famotidine tablets, clarithromycin sustained release tablets and diclofenac sodium enteric-coated tablets. With drug import-export operation right, the company export 70% of its paracetamol products to international markets. Baikang has passed GMP certification and its paracetamol product has gained registration certificate in India and Russia.